Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.08M Sell
165,090
-19,875
-11% -$854K 1.21% 33
2025
Q4
$8.11M Buy
184,965
+2,415
+1% +$99.9K 1.33% 29
2025
Q3
$7.54M Sell
182,550
-750
-0.4% -$30.1K 1.18% 31
2025
Q2
$8.08M Sell
183,300
-76,310
-29% -$3.05M 1.38% 30
2025
Q1
$9.58M Sell
259,610
-74,435
-22% -$2.65M 1.66% 27
2024
Q4
$11.1M Sell
334,045
-31,225
-9% -$1.01M 1.99% 21
2024
Q3
$9.48M Buy
365,270
+25,350
+7% +$630K 1.68% 26
2024
Q2
$7.64M Sell
339,920
-119,860
-26% -$2.66M 1.53% 29
2024
Q1
$10.9M Buy
459,780
+68,185
+17% +$1.52M 2.08% 18
2023
Q4
$9.39M Buy
391,595
+26,911
+7% +$585K 1.85% 24
2023
Q3
$7.97M Buy
364,684
+1,330
+0.4% +$27.8K 1.8% 25
2023
Q2
$6.94M Buy
363,354
+9,539
+3% +$184K 1.49% 30
2023
Q1
$6.87M Sell
353,815
-78,573
-18% -$1.37M 1.58% 27
2022
Q4
$6.94M Sell
432,388
-76,105
-15% -$1.24M 1.71% 27
2022
Q3
$7.97M Sell
508,493
-38,615
-7% -$746K 2.25% 16
2022
Q2
$11.4M Buy
547,108
+97,900
+22% +$2.02M 2.82% 12
2022
Q1
$10.2M Buy
449,208
+11,725
+3% +$229K 2.18% 19
2021
Q4
$8M Sell
437,483
-131,800
-23% -$2.52M 1.66% 26
2021
Q3
$12M Buy
569,283
+160,800
+39% +$2.99M 2.63% 13
2021
Q2
$7.44M Buy
408,483
+96,823
+31% +$2.26M 1.58% 27
2021
Q1
$7.04M Buy
311,660
+44,104
+16% +$996K 1.57% 30
2020
Q4
$5.37M Buy
267,556
+134,266
+101% +$2.81M 1.47% 29
2020
Q3
$3.26M Buy
133,290
+55,725
+72% +$1.3M 1.02% 34
2020
Q2
$1.84M Sell
77,565
-106,330
-58% -$2.46M 0.61% 38
2020
Q1
$3.17M Sell
183,895
-47,985
-21% -$878K 1.16% 33
2019
Q4
$4.09M Buy
231,880
+30,885
+15% +$524K 1.04% 37
2019
Q3
$3.56M Sell
200,995
-36,860
-15% -$746K 0.97% 39
2019
Q2
$5.08M Sell
237,855
-21,540
-8% -$451K 1.4% 36
2019
Q1
$6.17M Sell
259,395
-86,180
-25% -$1.97M 1.7% 28
2018
Q4
$6.8M Buy
345,575
+60,000
+21% +$1.07M 2.11% 24
2018
Q3
$5.06M Buy
+285,575
New +$5.57M 1.29% 33

Other funds holding EXEL

Capital Management's EXEL Position: Q1 2026 in Review

Capital Management reduced its Exelixis (EXEL) stake by 11% in Q1 2026, selling an estimated $854K and leaving 165,090 shares worth $7.08M. The position accounts for 1.21% of the portfolio, ranked #33.

Capital Management first reported a position in EXEL in Q3 2018 and has held it in 31 quarters since. The position peaked at $12M in Q3 2021. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Capital Management held 165,090 shares of Exelixis worth $7.08M as of Q1 2026.
  • Capital Management sold 19,875 Exelixis shares in Q1 2026, an estimated $854K.
  • Exelixis made up 1.21% of Capital Management's portfolio in Q1 2026, its #33 holding.
  • Capital Management first reported a position in Exelixis in Q3 2018 and has held it in 31 quarters since.
  • Capital Management's Exelixis position peaked at $12M in Q3 2021.
  • 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.